DIAGNOS: Private Placement Closing Update

Diagnos Inc.

BROSSARD, QUEBEC--(Marketwired - April 28, 2017) - Diagnos Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in early detection of critical health issues through the use of Artificial Intelligence, announces an update to the April 27th, 2017 news release on the closing of the private placement with regards to the number of related parties, within the meaning of Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"), who participated in the private placement.